Statement from Professor Ewan McKendrick, Registrar of Oxford University, regarding BBC’s File on 4 programme (6 June 2017) examining the role of animal experiments in the development of a new human vaccine for tuberculosis.
Jenner scientist Dr Rachel Tanner has been awarded an NC3Rs Skills and Knowledge Transfer Grant for the transfer of a novel non-human primate in vitro mycobacterial growth inhibition assay. The assay will be transferred to Public Health England and the Biomedical Primate Research Centre, with the aim of refining and reducing use of non-human primate TB infection models in the early evaluation of TB vaccine candidates.
Nanoassembly routes stimulate conflicting antibody quantity and quality for transmission-blocking malaria vaccines. Sci Rep, 7 (1), pp. 3811. Article
Human vaccination against Plasmodium vivax Duffy-binding protein induces strain-transcending antibodies. JCI Insight, 2 (12). Article
Clinical trials are an essential part of vaccine development, and our volunteers play a critical role in our studies.
If you would like to find out more about paid clinical trials, and what is involved in participating, please go to our Recruiting Trials page to see which trials are currently recruiting.
Dr Richard Webby: Swine influenza; a potpourri of pork and pathogen, 26/Jul/2017 16:00
Dr Pip Beard: The story of lumpy skin disease in Europe - impact and response to the rapid emergence of a poxviral transboundary disease of cattle, 18/Aug/2017 12:00